MAYO CLINIC

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1889-01-01

Employees: 10K

Market Cap: -

Website: http://www.mayoclinic.org

Clinical Trials

Oral and Intravenous Methadone for Analgesia in Cardiac Surgery

Phase 4

Not yet recruiting

Conditions: Anesthesia
Cardiac Surgery

Interventions: Drug: Intravenous methadone
Drug: Oral methadone, immediately prior to transport

First Posted Date: 2024-12-06

Last Posted Date: 2024-12-06

Lead Sponsor: Mayo Clinic

Target Recruit Count: 40

Registration Number: NCT06720415

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

How Many Dexamethasone Doses Should Be Given Perioperatively?

Phase 4

Not yet recruiting

Conditions: Arthropathy of Knee

Interventions: Drug: Dexamethasone IV
Drug: Dexamethasone IV+Oral
Drug: Dexamethasone IV+Oral 2 Day

First Posted Date: 2024-12-04

Last Posted Date: 2024-12-09

Lead Sponsor: Mayo Clinic

Target Recruit Count: 339

Registration Number: NCT06715709

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Q702 for the Treatment of Patients With Hematologic Malignancies

Phase 1

Not yet recruiting

Conditions: Central Nervous System Lymphoma
Hematopoietic and Lymphatic System Neoplasm
Histiocytic Sarcoma
Malignant Histiocytosis
Peripheral T-Cell Lymphoma, Not Otherwise Specified
Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
Recurrent Chronic Lymphocytic Leukemia
Recurrent Chronic Myelomonocytic Leukemia
Recurrent Follicular Lymphoma
Recurrent Langerhans Cell Histiocytosis

Interventions: Drug: Axl/Mer/CSF1R Inhibitor Q702
Procedure: Biospecimen Collection
Procedure: Bone Marrow Aspiration
Procedure: Bone Marrow Biopsy
Procedure: Computed Tomography
Procedure: Magnetic Resonance Imaging
Procedure: Positron Emission Tomography
Other: Survey Administration

First Posted Date: 2024-12-02

Last Posted Date: 2024-12-04

Lead Sponsor: Mayo Clinic

Target Recruit Count: 46

Registration Number: NCT06712810

Locations: 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States
🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial

Phase 1

Not yet recruiting

Conditions: Non-Muscle Invasive Bladder Carcinoma
Stage 0 Gallbladder Cancer AJCC V8
Stage I Bladder Cancer AJCC V8

Interventions: Biological: BCG Solution
Procedure: Cystoscopy
Drug: Docetaxel
Drug: Gemcitabine
Other: Home Health Encounter
Drug: Mitomycin
Other: Questionnaire Administration

First Posted Date: 2024-11-26

Last Posted Date: 2024-12-03

Lead Sponsor: Mayo Clinic

Target Recruit Count: 40

Registration Number: NCT06704191

Locations: 🇺🇸
Mayo Clinic in Florida, Jacksonville, Florida, United States

High Flow Nasal Cannula Compared to Standard Oxygen for Endoscopic Ultrasound

Not Applicable

Not yet recruiting

Conditions: Endoscopic Ultrasound

First Posted Date: 2024-11-26

Last Posted Date: 2024-11-26

Lead Sponsor: Mayo Clinic

Target Recruit Count: 200

Registration Number: NCT06704867

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

InBody Band 3 Fitness Tracker to Improve Health Outcomes and Quality of Life in Black Prostate Cancer Survivors

Not Applicable

Recruiting

Conditions: Prostate Carcinoma

First Posted Date: 2024-11-25

Last Posted Date: 2024-11-25

Lead Sponsor: Mayo Clinic

Target Recruit Count: 20

Registration Number: NCT06703996

Locations: 🇺🇸
Mayo Clinic in Florida, Jacksonville, Florida, United States

Thalamus Seizure Detection with a Deep Brain Stimulator System

Not Applicable

Not yet recruiting

Conditions: Epilepsy; Seizure

First Posted Date: 2024-11-22

Last Posted Date: 2024-12-13

Lead Sponsor: Mayo Clinic

Target Recruit Count: 5

Registration Number: NCT06700356

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Electromagnetic Transduction Therapy on Osteoarthritis in the Foot and Ankle

Not Applicable

Not yet recruiting

Conditions: Osteoarthritis Ankle
Osteoarthritis Foot

First Posted Date: 2024-11-20

Last Posted Date: 2024-11-20

Lead Sponsor: Mayo Clinic

Target Recruit Count: 20

Registration Number: NCT06696118

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

A Study of Mobility Outcomes in Post-Pulmonary Embolic Disease

Not Applicable

Not yet recruiting

Conditions: Pulmonary Embolism

First Posted Date: 2024-11-19

Last Posted Date: 2024-12-12

Lead Sponsor: Mayo Clinic

Target Recruit Count: 100

Registration Number: NCT06695247

A Study of Entresto in Tetralogy of Fallot (TOF) and Ebstein's Anomaly (EA)

Phase 3

Not yet recruiting

Conditions: Tetralogy of Fallot
Ebstein's Anomaly

Interventions: Drug: Entresto Pill
Other: Placebo

First Posted Date: 2024-11-18

Last Posted Date: 2024-11-18

Lead Sponsor: Mayo Clinic

Target Recruit Count: 45

Registration Number: NCT06693674

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Home Terms & Conditions Privacy Policy